Cargando…
Early Dual-Antiplatelet Therapy at the Emergency Department Is Associated with Lower In-Hospital Major Adverse Cardiac Event Risk among Patients with Non-ST-Elevation Myocardial Infarction
BACKGROUND: Dual antiplatelet therapy (DAPT) is a standard treatment in non-ST-segment-elevation myocardial infarction (NSTEMI). However, the timing of initiation of DAPT in the Emergency Department (ED) is not well established. The purpose of this study is to demonstrate the correlation between the...
Autores principales: | Yang, Jen-Han, Shih, Hong-Mo, Pan, Yan-Cheng, Chang, Shih-Sheng, Li, Chi-Yuan, Yu, Shao-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084641/ https://www.ncbi.nlm.nih.gov/pubmed/33968445 http://dx.doi.org/10.1155/2021/5571822 |
Ejemplares similares
-
Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
por: Shafiq, Ali, et al.
Publicado: (2016) -
Prognosis Between ST-Elevation and Non-ST-elevation Myocardial Infarction in Older Adult Patients
por: Chang, Shih-Sheng, et al.
Publicado: (2022) -
Spinal cord hemorrhage: a rare complication of dual antiplatelet therapy for non-ST elevation myocardial infarction
por: Yu, Xing, et al.
Publicado: (2019) -
Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021) -
Social media communication shorten door-to-balloon time in patients with ST-elevation myocardial infarction
por: Yu, Shao-Hua, et al.
Publicado: (2019)